OKYO NASDAQ
OKYO Pharma Limited
1W: +6.5%
1M: -9.3%
3M: -8.7%
YTD: -34.1%
1Y: -26.9%
3Y: -22.6%
$1.47
+0.13 (+9.70%)
Weekly Expected Move ±7.9%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
-227.8% ▼
Capital Expenditures
$6K
-403.3% ▼
5Y CAGR: -2.6%
Free Cash Flow
-$6M
-227.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$13M
+1675.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$13M | -$17M | -$8M | -$9M |
| Depreciation & Amort. | $2K | $4K | $4K | $3K | $2K |
| Stock-Based Comp. | $2M | $1M | $1M | $735K | $2M |
| Change in Working Capital | -$1M | $4M | $3M | $4M | -$630K |
| Other Non-Cash Items | $62K | -$84K | $4M | $2M | $2M |
| Operating Cash Flow | -$5M | -$8M | -$9M | -$2M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2K | -$6K | $0 | -$1K | -$6K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$6M |
| Investing Cash Flow | -$2K | -$6K | $0 | -$1K | -$6M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $2M | $0 | $950K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $726K | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2M | $9M | $6M | $3M | $25M |
| Net Change in Cash | -$4M | $1M | -$3M | $734K | $13M |
| Cash End of Period | $3M | $4M | $827K | $2M | $15M |
| Free Cash Flow | -$5M | -$8M | -$9M | -$2M | -$6M |